Nicotinamide riboside

DB14933ApprovedInvestigationalWithdrawnSmall molecule

Nicotinamide riboside is under investigation in clinical trial NCT03432871 (Nicotinamide Riboside and Mitochondrial Biogenesis).

Chemical structure of Nicotinamide riboside
Mechanism
Curator reviewed
Formula / weight
C11H15N2O5 · 255.2472 g/mol (avg)
Also known as
Nicotinamide ribonucleoside

Resolves to

Compound
UNII0I8H2M0L7NCAS1341-23-7ChEMBLCHEMBL438497ChEBI15927KEGGC03150
Structure
InChIKeyJLEBZPBDRKPWTD-TURQNECASA-OSMILESNC(=O)C1=C[N+](=CC=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Targets
Q9NPI5NMRK2Q9NWW6NMRK1

What you can answer from here — as of September 12, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
33Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Nicotinamide riboside, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In